We have added a new TMS device at our Cherry Hill Office:  Brainsway Deep TMS.  Deep TMS (dTMS) is a new technology that produces significantly deeper cortical stimulation.  Brainsway Deep TMS is approved by the FDA for Major Depressive Disorder.  The FDA indication is based on a 16-week double-blind, placebo-controlled multi-center study, which enrolled over 200 subjects, showing a profound decline in the Hamilton Depression Rating Scale (HDRS-21), a significant remission rate of 32.6% and an even higher response rate in treatment resistant patients.  Brainsway Deep TMS is currently being studied in over 60 clinical trials at leading institutions worldwide.  Approved clinical indications in Europe include Bipolar Disorder, PTSD, Schizophrenia (negative symptoms), Autism, Alzheimer’s disease, Parkinson’s disease, chronic pain and smoking cessation.